Michel R Franz

Title: Michel R Franz: Innovator in Pharmaceutical Compositions

Introduction

Michel R Franz is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work primarily focuses on developing innovative drug delivery systems that enhance the efficacy of pharmaceutical compositions.

Latest Patents

Among his latest patents is a stabilized pharmaceutical composition that comprises an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin. This invention relates to a solid pharmaceutical composition featuring two separate regions. Another notable patent is a sustained release bilayer buoyant dosage form. This dosage form includes a drug and is designed to release the drug over an extended period. It comprises a capsule with a non-compressed bi-layer formulation, where one layer is a drug release layer and the other is a buoyant or floating layer. This innovative pharmaceutical dosage form provides an extended gastric residence time, ensuring that substantially all of the drug is released in the stomach over an extended period. The floating layer is formulated to provide buoyancy and includes a polymer that hydrates upon contact with gastric fluid, forming a gelatinous barrier. This dosage form can remain buoyant in gastric fluid for up to about 13 hours.

Career Highlights

Throughout his career, Michel R Franz has worked with several prominent companies, including Continental Pharma Incorporated and G.D. Searle & Company. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Michel has collaborated with notable professionals in the field, including Georges E Lambelin and Paul J Niebes. Their collective efforts have further advanced the development of effective pharmaceutical solutions.

Conclusion

Michel R Franz is a distinguished inventor whose work in pharmaceutical compositions has led to significant advancements in drug delivery systems. His innovative patents and collaborations reflect his commitment to improving healthcare through effective pharmaceutical solutions.